Huntington Beach, CA, United States of America

George Baklayan

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by George Baklayan

Introduction

George Baklayan is a notable inventor based in Huntington Beach, California. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on enhancing the efficacy and delivery of various medicinal compositions.

Latest Patents

Among his latest patents, Baklayan has developed novel compositions that include bepotastine besilate and a corticosteroid. These compositions also feature at least about 0.008% w/v benzalkonium chloride and hydroxypropylmethyl cellulose E15 LV. Additionally, he has worked on formulations and methods that enhance bromfenac penetration into ocular tissue when topically administered. This innovation provides a more effective alternative to the currently available BROMDAY™ formulation while maintaining the convenience of once-daily administration and reducing the bromfenac concentration required for patients.

Career Highlights

Baklayan has had a successful career in the pharmaceutical industry, working with prominent companies such as Bausch & Lomb Pharma Holdings Corp. and Senju Pharmaceutical Co., Ltd. His expertise in developing innovative drug formulations has made a significant impact in the field.

Collaborations

Throughout his career, Baklayan has collaborated with talented individuals, including Angel Padilla and Shirou Sawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

George Baklayan's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through effective drug formulations. His work continues to influence the industry and enhance therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…